The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the tinzaparin that was provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.There was no specific cellex instrument serial number mentioned in the complaint; however, there are only two cellex instruments located at this customer's site, instrument serial numbers (b)(4).No product was returned; therefore, a device service history review was performed.Cellex instruments, (b)(4) , have been located at the customer's site since (b)(6) 2016.As part of the review, it was determined that prior to the event the instruments, (b)(4), underwent scheduled preventive maintenance on 01-mar-2017.The instruments' last service was performed on 27-feb-2018 and 28-feb-2018, respectively.During all of these services the system checkout procedure was successfully completed indicating that the instruments had passed all tests, met all specifications, and were operational.Trends were reviewed for complaint category, thrombosis.No trends were detected for this complaint category.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: thrombosis.(b)(4).
|
In a follow up with the customer on (b)(6) 2018, the customer stated that the patient continued with their extracorporeal photopheresis (ecp) treatments after their deep vein thrombosis diagnosis on (b)(6) 2017.The customer reported that the patient's ecp treatments are still ongoing.There was no specific cellex instrument serial number mentioned in the complaint, however there are only two cellex instruments at this site, 40616 and 40617.Instrument 40616 underwent preventive maintenance on (b)(6) 2017 prior to the adverse event.No service was requested by the customer for this adverse event.Following the event, instrument 40616 underwent unrelated service on (b)(6) 2017.During each of the services the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational each time.Instrument 40617 underwent service on (b)(6) 2017 prior to the patient's adverse event.No service was requested by the customer for this adverse event.Following the event, instrument 40617 underwent unrelated service on (b)(6) 2017.During each of the services the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational each time.(b)(4).
|